Biotechnology major Biocon’s Executive Chairperson Kiran Mazumdar-Shaw has tested positive for Coronavirus. Her bio-pharmaceutical company has been working to launch biologic drug Itolizumab for the treatment of moderate to severe COVID-19 patients at a price of around 8,000 per vial.

Taking to Twitter, Shaw said that she had been added to the Coronavirus tally.

Shaw recently said that India now needs to draw up its immunization strategy as the vaccine for COVID-19 will be ready anytime between “the end of this year to the middle of next year”.If the Bharat Biotech vaccine, or Zydus Cadila vaccine starts showing good, promising results, we could also have it (vaccine) by the end of the year, she said.

Follow on Google News
TOPICS: Biocon